Science News for August 27, 2022

Clinical trial, meta-analysis find diabetes drugs may benefit all heart failure patients

A meta-analysis of clinical trials found that SGLT2 inhibitors, like dapagliflozin and empagliflozin, reduce cardiovascular death and hospitalization in patients with mildly reduced or preserved ejection fraction heart failure. These drugs may benefit a wide range of patients, regardless of age, sex, or medical history.

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateAug 27, 2022

Weaving atomically thin seams of light with in-plane heterostructures

Scientists develop a method to produce atomically thin seams of light using in-plane heterostructures, enabling customizable strain and circularly polarized light. This technology has the potential to create efficient and chiral electroluminescence for applications in quantum optoelectronics.

SourceTokyo Metropolitan University·JournalAdvanced Functional Materials·DateAug 27, 2022

Autoimmune disorders increase risk of cardiovascular disease

A study of 22 million patients found that those with autoimmune disorders have a substantially higher risk of developing cardiovascular disease. The excess risk is similar to that of type 2 diabetes and affects the entire cardiovascular disease spectrum.

SourceKU Leuven·JournalThe Lancet·TypeObservational study·DateAug 27, 2022

Sky & Telescope Pocket Sky Atlas, 2nd Edition

Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.